|
|
|
Volumn 41, Issue 4, 1997, Pages 878-
|
|
New antimicrobial agents approved by the U.S. Food and Drug Administration in 1996 and new indications for previously approved agents
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN;
AMPHOTERICIN B CHOLESTEROL SULFATE;
AMPHOTERICIN B LIPID COMPLEX;
ANTIINFECTIVE AGENT;
AZITHROMYCIN;
CEFEPIME;
CEFPROZIL;
CIDOFOVIR;
CIPROFLOXACIN;
CLARITHROMYCIN;
FOSFOMYCIN;
FOSFOMYCIN TROMETAMOL;
INDINAVIR;
ITRACONAZOLE;
IVERMECTIN;
LEVOFLOXACIN;
MEROPENEM;
NEVIRAPINE;
OFLOXACIN;
RITONAVIR;
SPARFLOXACIN;
DRUG APPROVAL;
DRUG INDICATION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LOWER RESPIRATORY TRACT INFECTION;
MENINGITIS;
MYCOSIS;
ONCHOCERCIASIS;
ONYCHOMYCOSIS;
PEPTIC ULCER;
PRIORITY JOURNAL;
PROSTATITIS;
RETINITIS;
SHORT SURVEY;
SINUSITIS;
SKIN INFECTION;
STRONGYLOIDIASIS;
URINARY TRACT INFECTION;
|
|
EID: 0030891938
PISSN: 00664804
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|